Your browser doesn't support javascript.
loading
Ventricular assist devices in paediatric cardiomyopathy and congenital heart disease: An analysis of the German National Register for Congenital Heart Defects.
Lammers, Astrid Elisabeth; Sprenger, Katharina Sofie; Diller, Gerhard-Paul; Miera, Oliver; Lebherz, Corinna; Helm, Paul C; Abdul-Khaliq, Hashim; Asfour, Boulos; Ewert, Peter; Bauer, Ulrike M M; Kehl, Hans-Gerd; Humpl, Tilman; Warnecke, Gregor; Baumgartner, Helmut; Berger, Felix; Tutarel, Oktay.
Affiliation
  • Lammers AE; Department of Cardiology III - Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Germany; Department of Paediatric Cardiology, University Hospital Muenster, Germany; Competence Network for Congenital Heart Defects Berlin, Germany. Electronic address: astrid.lammers@ukmuenste
  • Sprenger KS; Department of Paediatric Cardiology, University Hospital Muenster, Germany.
  • Diller GP; Department of Cardiology III - Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Germany; Competence Network for Congenital Heart Defects Berlin, Germany.
  • Miera O; Department of Congenital Heart Disease-Pediatric Cardiology, German Heart Institute Berlin, Germany.
  • Lebherz C; Department of Cardiology, University Hospital RWTH Aachen, Germany.
  • Helm PC; Competence Network for Congenital Heart Defects Berlin, Germany; National Register for Congenital Heart Defects, Berlin, Germany.
  • Abdul-Khaliq H; Competence Network for Congenital Heart Defects Berlin, Germany; Department for Paediatric Cardiology, Homburg, Germany.
  • Asfour B; Department for Congenital Cardiac Surgery, Bonn, Germany.
  • Ewert P; Department of Congenital Heart Disease and Paediatric Cardiology, German Heart Centre Munich, TUM School of Medicine, Technical University of Munich, Germany.
  • Bauer UMM; Competence Network for Congenital Heart Defects Berlin, Germany; National Register for Congenital Heart Defects, Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Germany.
  • Kehl HG; Department of Paediatric Cardiology, University Hospital Muenster, Germany.
  • Humpl T; Inselspital Bern, Switzerland.
  • Warnecke G; Department of Cardiothoracic Surgery, University Hospital Heidelberg, Germany.
  • Baumgartner H; Department of Cardiology III - Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Germany; Competence Network for Congenital Heart Defects Berlin, Germany.
  • Berger F; Department of Congenital Heart Disease-Pediatric Cardiology, German Heart Institute Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Germany.
  • Tutarel O; Competence Network for Congenital Heart Defects Berlin, Germany; Department of Congenital Heart Disease and Paediatric Cardiology, German Heart Centre Munich, TUM School of Medicine, Technical University of Munich, Germany; DZHK (German Center for Cardiovascular Research), partner site Munich Heart
Int J Cardiol ; 343: 37-44, 2021 Nov 15.
Article in En | MEDLINE | ID: mdl-34487787
BACKGROUND: Ventricular assist devices (VAD) are increasingly used in patients with end-stage heart failure due to acquired heart disease. Limited data exists on the use and outcome of this technology in children. METHODS: All children (<18 years of age) with VAD support included in the German National Register for Congenital Heart Defects were identified and data on demographics, underlying cardiac defect, previous surgery, associated conditions, type of procedure, complications and outcome were collected. RESULTS: Overall, 64 patients (median age 2.1 years; 45.3% female) receiving a VAD between 1999 and 2015 at 8 German centres were included in the analysis. The underlying diagnosis was congenital heart disease (CHD) in 25 and cardiomyopathy in 39 children. The number of reported VAD implantations increased from 13 in the time period 2000-2004 to 27 implantations in the time period 2010-2014. During a median duration of VAD support of 54 days, 28.1% of patients experienced bleeding complications (6.3% intracerebral bleeding), 14.1% thrombotic (10.9% VAD thrombosis) and 23.4% thromboembolic complications (including cerebral infarction in 18.8% of patients). Children with cardiomyopathy were more likely to receive a cardiac transplantation (79.5% vs. 28.0%) compared to CHD patients. Survival of cardiomyopathy patients was significantly better compared to the CHD cohort (p < 0.0001). Multivariate Cox-proportional analysis revealed a diagnosis of CHD (hazard ratio [HR] 4.04, p = 0.001), age at VAD implantation (HR 1.09/year, p = 0.04) and the need for pre-VAD extracorporeal membrane oxygenation (ECMO) support (HR 3.23, p = 0.03) as independent predictors of mortality. CONCLUSIONS: The uptake of VAD therapy in children is increasing. Morbidity and mortality remain high, especially in patients with congenital heart disease and those requiring ECMO before VAD implantation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart-Assist Devices / Heart Transplantation / Heart Defects, Congenital / Heart Failure / Cardiomyopathies Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Child, preschool / Female / Humans / Male Language: En Journal: Int J Cardiol Year: 2021 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart-Assist Devices / Heart Transplantation / Heart Defects, Congenital / Heart Failure / Cardiomyopathies Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Child, preschool / Female / Humans / Male Language: En Journal: Int J Cardiol Year: 2021 Type: Article